Researchers from the Centers of Disease Control and Prevention (CDC) have determined that most primary care providers still recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest...
New Study Explores Immune System Stimulation In Battle Against HER-2/neu Positive Breast Cancer
8/18/2011
The Mayo Clinic is excited to announce a Phase I study of a new therapeutic vaccine in HER-2/neu positive breast cancer patients in the fourth quarter of 2011. To understand the importance of this development, the HER-2/neu and the significance of HER-2/neu positive breast cancer must be examined...
Association Found Between Vitamin D Levels And Risk Of Skin Cancer
8/18/2011
A new report by JAMA, published Online First by Archives of Dermatology, has found an association between a person's vitamin D levels and risk of non-melanoma skin cancer (NMSC). The report observed that when an individual's vitamin D level increases, their risk of developing NMSC seems to increase too. They noted that factors such as UV radiation exposure could complicate the relationship though...
Need For Quality Measures Highlighted By Variations In Bowel Re-Operation Rates
8/18/2011
According to a study published yesterday on bmj.com, English NHS hospitals have a large variation in unplanned re-operation rates after colorectal surgery. Researchers recommend using re-operation rates alongside other quality measures to help improve surgical performance on a national scale...
Colorectal Cancer Reduced By Single Flexible Sigmoidoscopy Screening
8/18/2011
According to an investigation published online today in the Journal of National Cancer Institute, a single flexible sigmoidoscopy screening between the ages of 55-64 years is linked with a reduced level of colorectal cancer (CRC) incidence and mortality...
Patients With Serious Blood Clot Risk Detected By New Risk Score
8/18/2011
A study published on bmj.com yesterday revealed a new risk prediction tool that can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might require preventative treatment...
Man's Best Friend Able To Sniff Out Lung Cancer Before Doctors Detect
8/18/2011
Man's best friend, the dog, may also be a lifesaver. New research finds that super trained pups are able to sniff out lung cancer in a human's breath, making detection easier and earlier for doctors. This will allow them to treat the ailment earlier and save more lives. Nice...
Risk Of Bladder Cancer Due To Smoking Higher Than We Thought
8/18/2011
According to a study in the August 17 issue of JAMA, an analysis of data from almost 500,000 individuals indicates, that the risk of bladder cancer among smokers is higher than reported from previous population data, and that the risk for female smokers is comparable with that of men...
Sex After Prostate Surgery And New Techniques To Improve It
8/18/2011
Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center knows the wide range of emotions and fears that men with prostate cancer face. As a robotic prostatectomy and prostate cancer treatment expert, Dr. Samadi cares for the total patient, helping them deal with all aspects of treatment, recovery and cure...
FDA Approves Zelboraf And Companion Diagnostic Test For Late-Stage Skin Cancer
8/18/2011
The U.S. Food and Drug Administration approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer. Zelboraf is specifically indicated for the treatment of patients with melanoma whose tumors express a gene mutation called BRAF V600E...